Misinformation Could Thwart the Potential of Cancer Vaccines 

For a long time, scientists have been working tirelessly to come up with vaccines against cancer. Significant progress is being registered in developing mRNA vaccines against cancer, but this progress has come up against a wall of misinformation that could thwart the prospects of this promising intervention.

Public health officials need to take on this threat and proactively feed the public the right information so that all proven treatment approaches can be leveraged in the fight against diseases like cancer. Today the misinformation infodemic could be targeting mRNA vaccines, tomorrow it could affect other therapy approaches like the fields in which companies like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are active&

Read More>> 

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN

You May Also Be Interested In

• The Demand for Flexible Spaces Continues to Grow: Why Glass Is Becoming the Material of Choice in Modern Interiors
• Intech Hawaii Strengthens CMMC Leadership with Second CMMC Certified Assessor on Staff
• Altamira Gold Secures Land Access to High-Priority Gold Targets, Unlocking a New Phase of Exploration in the West of the Cajueiro Gold District, Brazil